Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study

✍ Scribed by Kakolyris, S.; Papadakis, E.; Tsiafaki, X.; Kalofonos, C.; Rapti, A.; Toubis, M.; Bania, E.; Kouroussis, Ch.; Chainis, K.; Androulakis, N.; Agelaki, S.; Sarra, E.; Vardakis, N.; Georgoulias, V.

• Book ID: 118569505
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 94 KB
• Volume: 32
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(00)00212-9